Erik Laursen

Consulente / Consigliere presso Propel Bio Partners LLC

Finance

Consumer Services

Health Technology

Posizioni attive di Erik Laursen

Società	Posizione	Inizio	Fine
Propel Bio Partners LLC Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California.	Consulente / Consigliere	-	-

Società	Posizione	Inizio	Fine
Rentschler Biotechnologie Beteiligungs GmbH Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the company are Jürgen Müller, Nikolaus Friedrich Rentschler.	Vendite & Marketing	01/09/2011	01/03/2013
Cmc Biologics A/S	Corporate Officer/Principal	01/08/2005	01/09/2010
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Corporate Officer/Principal	01/01/1988	01/01/1996

Technical University of Denmark

Graduate Degree

Distribuzione geografica

Posizioni

Corporate Officer/Principal	2
Consultant / Advisor	1
Graduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	4
Propel Bio Partners LLC Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California.	Finance
Rentschler Biotechnologie Beteiligungs GmbH Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the company are Jürgen Müller, Nikolaus Friedrich Rentschler.	Finance
Cmc Biologics A/S
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology